Quick Answer
AMGEN INC reported Operating Income of $9.08 billion for fiscal year 2025.
AMGEN INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $9.08B | +25.1% |
| 2024 | $7.26B | -8.1% |
| 2023 | $7.90B | -17.4% |
| 2022 | $9.57B | +25.2% |
| 2021 | $7.64B | -16.4% |
| 2020 | $9.14B | -5.5% |
| 2019 | $9.67B | -5.7% |
| 2018 | $10.26B | +2.9% |
| 2017 | $9.97B | +1.8% |
| 2016 | $9.79B | +15.6% |
| 2015 | $8.47B | +36.8% |
| 2014 | $6.19B | +5.5% |
| 2013 | $5.87B | +5.2% |
| 2012 | $5.58B | +29.3% |
| 2011 | $4.31B | -22.2% |
| 2010 | $5.54B | +0.7% |
| 2009 | $5.51B | +5.6% |
| 2008 | $5.21B | +31.0% |
| 2007 | $3.98B | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.53B | +23.4% | -4.9% |
| June 30, 2025 | $2.66B | +39.1% | +125.5% |
| March 31, 2025 | $1.18B | +18.9% | -42.5% |
| September 30, 2024 | $2.05B | +1.3% | +7.2% |
| June 30, 2024 | $1.91B | -28.9% | +92.6% |
| March 31, 2024 | $991.00M | -48.4% | -51.0% |
| September 30, 2023 | $2.02B | -24.0% | -24.7% |
| June 30, 2023 | $2.68B | +23.3% | +39.7% |
- AMGEN INC showed an increase of +25.1% in Operating Income compared to the prior fiscal year.
- Over the 2007–2025 period, AMGEN INC’s operating income has grown by 128.1% (from $3.98 billion to $9.08 billion).
- The most recent figure is from AMGEN INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: